期刊
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
卷 139, 期 2, 页码 178-183出版社
AMER DENTAL ASSOC
DOI: 10.14219/jada.archive.2008.0134
关键词
chlorhexidine gluconate; mouthrinse; periodontal disease; diabetes
资金
- NIDCR NIH HHS [K24 DE 018211, K24 DE 00419] Funding Source: Medline
Background. The authors report adverse events, (AEs) related to the use of chlorhexidine gluconate mouthrinse in a clinical trial of the efficacy of periodontal treatment in older adults with diabetes. Methods. Participants were U.S. veterans with uncontrolled diabetes (hemoglobin A(1c) value >= 8.5 percent) and periodontal disease. Treatment included periodontal scaling, 0.12 percent chlorhexidine lavage during ultrasonic scaling and use of chlorhexidine mouthrinse at home. Results. Forty-four (31 percent) of 140 subjects reported having AEs. Most common were taste changes and tooth. staining, sore mouth and/or throat, tongue irritation and wheezing/shortness of breath; the latter was reported more commonly before chlorhexidine use than after. Only body mass index greater than 30 was significantly related to AEs. Conclusions. AEs are common among subjects using chlorhexidine mouthrinse: Most AEs (taste change and staining) were resolved easily by subjects' discontinuing mouthrinse use and receiving dental prophylaxis. No serious AEs were reported. Clinical Implications. Clinicians should advise patients using. chlorhexidine mouthrinse of possible side effects If necessary, patients, should discontinue mouthrinse use and obtain medical care. Careful monitoring of AEs in patients using chlorhexidine is warranted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据